Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar;13(3):1788-95.
doi: 10.1128/mcb.13.3.1788-1795.1993.

Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors

Affiliations

Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors

O Miura et al. Mol Cell Biol. 1993 Mar.

Abstract

The cytoplasmic domain of the erythropoietin receptor (EpoR) contains a region, proximal to the transmembrane domain, that is essential for function and has homology with other members of the cytokine receptor family. To explore the functional significance of this region and to identify critical residues, we introduced several amino acid substitutions and examined their effects on erythropoietin-induced mitogenesis, tyrosine phosphorylation, and expression of immediate-early (c-fos, c-myc, and egr-1) and early (ornithine decarboxylase and T-cell receptor gamma) genes in interleukin-3-dependent cell lines. Amino acid substitution of W-282, which is strictly conserved at the middle portion of the homology region, completely abolished all the functions of the EpoR. Point mutation at L-306 or E-307, both of which are in a conserved LEVL motif, drastically impaired the function of the receptor in all assays. Other point mutations, introduced into less conserved amino acid residues, did not significantly impair the function of the receptor. These results demonstrate that conserved amino acid residues in this domain of the EpoR are required for mitogenesis, stimulation of tyrosine phosphorylation, and induction of immediate-early and early genes.

PubMed Disclaimer

References

    1. EMBO J. 1986 Feb;5(2):317-23 - PubMed
    1. Cell. 1985 Jul;41(3):685-93 - PubMed
    1. Science. 1987 Jun 5;236(4806):1229-37 - PubMed
    1. Oncogene Res. 1987 Aug;1(3):279-96 - PubMed
    1. Oncogene Res. 1988 Feb;2(3):277-84 - PubMed

Publication types

MeSH terms

LinkOut - more resources